| Literature DB >> 31065582 |
Tatyana Mollayeva1,2,3, Mackenzie Hurst2, Michael Escobar4, Angela Colantonio1,2,3.
Abstract
INTRODUCTION: Despite evidence that central nervous system (CNS) trauma, including traumatic brain injury and spinal cord injury, can cause sustained neurocognitive impairment, it remains unclear whether trauma-related variables are associated with incident dementia independently of other known risk factors.Entities:
Keywords: Comorbidity; Dementia; Prognostic modeling; Risk factors; Spinal cord injury; Traumatic brain injury
Year: 2019 PMID: 31065582 PMCID: PMC6495080 DOI: 10.1016/j.dadm.2019.03.003
Source DB: PubMed Journal: Alzheimers Dement (Amst) ISSN: 2352-8729
Fig. 1Hypothesized relationships related to dementia outcome after central nervous system trauma. Red color indicates previously unexplored hypothesis. Black color indicates other tested relationships, previously described. *The following variables were evaluated as predictors in our statistical models: (1) TBI severity, (2) presence of comorbid SCI, (3) the interaction of TBI severity and age, and (4) the interaction of comorbid SCI and age. Abbreviations: SCI, spinal cord injury; TBI, traumatic brain injury.
Characteristics of patients who did develop dementia (n = 32,834) and those who did not (n = 679,874)
| Variables | Total | With dementia | Without dementia | TBI severity | Comorbid SCI | ||||
|---|---|---|---|---|---|---|---|---|---|
| Mild | Moderate | Severe | Unspecified | Present | Absent | ||||
| n = 712,708 | n = 32,834 | n = 679,874 | n = 443,456 | n = 7365 | n = 17,390 | n = 244,497 | n = 29,695 | n = 683,013 | |
| Sociodemographic characteristics | |||||||||
| Male | 423,657 (59.44) | 13,342 (40.63) | 410,315 (60.35) | 293,264 (66.13) | 4920 (66.80) | 11,421 (65.68) | 114,052 (46.65) | 15,681 (52.81) | 407,976 (59.73) |
| Age at first TBI (years) | 44.00 (27.00–64.00) | 82.00 (76.00–87.00) | 42.00 (26.00–60.00) | 43.00 (27.00–63.00) | 49.00 (30.00–71.00) | 59.00 (38.00–77.00) | 44.00 (27.00–64.00) | 49.00 (31.00–73.00) | 44.00 (27.00–64.00) |
| Income Q1 (poorest) | 156,172 (21.91) | 7686 (23.41) | 148,486 (21.84) | 94,956 (21.41) | 1750 (23.76) | 3890 (22.37) | 55,576 (22.73) | 6878 (23.16) | 149,294 (21.86) |
| Income Q2 | 145,034 (20.35) | 7012 (21.36) | 138,022 (20.30) | 89,573 (20.20) | 1565 (21.25) | 3628 (20.86) | 50,268 (20.56) | 6257 (21.07) | 138,777 (20.32) |
| Income Q3 | 139,368 (19.55) | 6277 (19.12) | 133,091 (19.58) | 86,787 (19.57) | 1340 (18.19) | 3367 (19.36) | 47,874 (19.58) | 5931 (19.97) | 133,437 (19.54) |
| Income Q4 | 138,508 (19.43) | 5953 (18.13) | 132,555 (19.50) | 86,927 (19.60) | 1381 (18.75) | 3409 (19.60) | 46,791 (19.14) | 5556 (18.71) | 132,952 (19.47) |
| Income Q5 (wealthiest) | 133,626 (18.75) | 5906 (17.99) | 127,720 (18.79) | 85,213 (19.22) | 1329 (18.04) | 3096 (17.80) | 43,988 (17.99) | 5073 (17.08) | 128,553 (18.82) |
| Rural residence | 101,346 (14.22) | 4075 (12.41) | 97,271 (14.31) | 65,925 (14.87) | 982 (13.33) | 2395 (13.77) | 32,044 (13.11) | 5220 (17.58) | 96,126 (14.07) |
| Disorders of circulatory system | |||||||||
| Cerebrovascular disease | 19,207 (2.69) | 3386 (10.31) | 15,821 (2.33) | 8954 (2.02) | 624 (8.47) | 3157 (18.15) | 6472 (2.65) | 1230 (4.14) | 17,977 (2.63) |
| Ischemic heart disease | 36,312 (5.09) | 5212 (15.87) | 31,100 (4.57) | 20,512 (4.63) | 527 (7.16) | 1927 (11.08) | 13,346 (5.46) | 2364 (7.96) | 33,948 (4.97) |
| Atrial fibrillation | 22,014 (3.09) | 3623 (11.03) | 18,391 (2.71) | 12,009 (2.71) | 360 (4.89) | 1572 (9.04) | 8073 (3.30) | 1508 (5.08) | 20,506 (3.00) |
| Heart failure | 17,248 (2.42) | 2872 (8.75) | 14,376 (2.11) | 9582 (2.16) | 258 (3.50) | 1015 (5.84) | 6393 (2.61) | 1133 (3.82) | 16,115 (2.36) |
| Disorders of vascular system | |||||||||
| Obesity | 3903 (0.55) | 242 (0.74) | 3661 (0.54) | 1895 (0.43) | 36 (0.49) | 127 (0.73) | 1845 (0.75) | 274 (0.92) | 3629 (0.53) |
| Hyperlipidemia | 12,312 (1.73) | 1843 (5.61) | 10,469 (1.54) | 6718 (1.51) | 205 (2.78) | 693 (3.99) | 4696 (1.92) | 817 (2.75) | 11,495 (1.68) |
| Diabetes mellitus | 48,138 (6.75) | 6518 (19.85) | 41,620 (6.12) | 25,791 (5.82) | 701 (9.52) | 2312 (13.29) | 19,334 (7.91) | 2874 (9.68) | 45,264 (6.63) |
| Other disorders and signs | |||||||||
| Tobacco smoking | 870 (0.12) | 51 (0.16) | 819 (0.12) | 497 (0.11) | 15 (0.20) | 33 (0.19) | 325 (0.13) | 56 (0.19) | 814 (0.12) |
| Depression | 25,746 (3.61) | 1612 (4.91) | 24,134 (3.55) | 13,646 (3.08) | 343 (4.66) | 798 (4.59) | 10,959 (4.48) | 2010 (6.77) | 23,736 (3.48) |
| Visual impairments | 7630 (1.07) | 1121 (3.41) | 6509 (0.96) | 4373 (0.99) | 120 (1.63) | 344 (1.98) | 2793 (1.14) | 489 (1.65) | 7141 (1.05) |
| Hearing loss | 1689 (0.24) | 168 (0.51) | 1521 (0.22) | 901 (0.20) | 28 (0.38) | 111 (0.64) | 649 (0.27) | 125 (0.42) | 1564 (0.23) |
| Sleep disorder (any) | 6999 (0.98) | 537 (1.64) | 6462 (0.95) | 3818 (0.86) | 90 (1.22) | 230 (1.32) | 2861 (1.17) | 556 (1.87) | 6443 (0.94) |
| Incidents | |||||||||
| Dementia | 32,834 (4.61) | 32,834 (100.00) | - | 19,401 (4.37) | 405 (5.50) | 1117 (6.42) | 11,911 (4.87) | 2349 (7.91) | 30,485 (4.46) |
| Alzheimer's disease | 8451 (1.19) | 8451 (25.74) | - | 5078 (1.15) | 88 (1.19) | 252 (1.45) | 3033 (1.24) | 517 (1.74) | 7934 (1.16) |
| Follow-up time, in months | |||||||||
| To dementia | 25.00 (8.18–52.40) | 25.00 (8.18–52.40) | - | 25.53 (8.64–52.88) | 20.60 (3.52–51.84) | 32.82 (7.64–65.18) | 23.66 (7.59–50.18) | 28.32 (9.61–57.03) | 24.67 (8.08–52.01) |
NOTE. Data are given as median (interquartile range) or n (%).
Abbreviations: Q, quantile; SCI, spinal cord injury; TBI, traumatic brain injury.
Model fitting and effect (HR and 95% CI), including regression coefficients (ß) and level of significance (ρ), of CNS trauma expressed by TBI severity and SCI comorbidity, controlling for potential confounders and risk factors for dementia
| Regression coefficients/predictors/ | Dementia model | ||
|---|---|---|---|
| Simplest; ß/HR (95% CI) ρ | Simplest + interaction of TBI severity with age; ß/HR (95% CI) ρ | Simplest + interaction of SCI with age; ß/HR (95% CI) ρ | |
| TBI severity | |||
| Mild (yes) | 1 | 1 | 1 |
| Unknown severity (concussion codes) versus mild | 0.09/1.10 (1.07–1.12)**** | 0.42/ | 0.09/1.10 (1.07–1.12)**** |
| 0.16/1.17 (1.13–1.22)**** | 0.78/ | 0.16/1.17 (1.13–1.22)**** | |
| 0.05/1.05 (1.02–1.08)*** | 0.02/ | 0.05/1.05 (1.02–1.08)*** | |
| Moderate versus mild | 0.11/1.12 (1.02–1.24)*** | 0.31/ | 0.11/1.12 (1.01–1.23)*** |
| −0.02/0.98 (0.84–1.15) | 0.16/ | −0.02/.98 (0.83–1.14) | |
| 0.21/1.23 (1.09–1.40)*** | 0.82/ | 0.21/1.23 (1.08–1.40)*** | |
| Severe versus mild | −0.04/0.97 (0.91–1.03) | 1.65/ | −0.04/0.96 (0.91–1.02) |
| −0.06/0.94 (0.86–1.02) | 1.96/ | −0.07/0.94 (0.86–1.02) | |
| 0.00/1.00 (0.92–1.09) | 1.47/ | 0.00/1.00 (0.91–1.09) | |
| Mild (yes) | 1 | 1 | 1 |
| SCI comorbidity | |||
| SCI (yes vs. no) | 0.08/1.08 (1.03–1.12)*** | 0.07/1.08 (1.03–1.12)*** | 1.35/( |
| 0.12/1.13 (1.06–1.21)*** | 0.12/1.13 (1.06–1.21)*** | 1.79/( | |
| 0.05/1.05 (1.00–1.11) | 0.05/1.05 (1.00–1.12) | 0.91/( | |
| Sex | |||
| Women | −0.13/0.88 (0.86–0.90)**** | −0.13/0.88 (0.86–0.90)**** | −0.13/0.88 (0.86–0.90)**** |
| Men | 1 | 1 | 1 |
| Age | −0.05/0.96 (0.90–1.01) | −0.05/ | −0.04/ |
| −0.11/0.90 (0.86–0.97)*** | −0.11/ | −0.10/ | |
| 0.02/1.02 (0.93–1.13) | 0.02/ | 0.02/ | |
| Age2 | 0.00/1.00 (1.00–1.00)**** | 0.00/1.00 (1.00–1.01)**** | 0.00/1.00 (1.00–1.01)**** |
| 0.01/1.01 (1.00–1.01)**** | 0.01/1.01 (1.00–1.01)**** | 0.01/1.01 (1.00–1.01)**** | |
| 0.00/1.00 (1.00–1.01)**** | 0.00/1.00 (1.00–1.01)**** | 0.00/1.00 (1.00–1.01)**** | |
| Age3 | 0.00/1.00 (1.00–1.00)**** | 0.00/1.00 (1.00–1.00)**** | 0.00/1.00 (1.00–1.00)**** |
| 0.00/1.00 (1.00–1.00)**** | 0.00/1.00 (1.00–1.00)**** | 0.00/1.00 (1.00–1.00)**** | |
| 0.00/1.00 (1.00–1.00)**** | 0.00/1.00 (1.00–1.00)**** | 0.00/1.00 (1.00–1.00)**** | |
| Controlling variables | |||
| Neighborhood income 2nd quantile versus 1st quantile (poorest) | −0.07/0.94 (0.91–0.97)**** | −0.07/0.94 (0.91–0.97)**** | −0.07/0.94 (0.91–0.97)**** |
| −0.10/0.90 (0.89–0.96)*** | −0.10/0.9105 (0.86–0.95)*** | −0.10/0.90 (0.86–0.95)*** | |
| −0.05/0.96 (0.92–0.99)*** | −0.05/0.96 (0.92–0.99)*** | −0.05/0.96 (0.92–0.99)*** | |
| Neighborhood income 3rd quantile versus 1st quantile | −0.08/0.92 (0.89–0.95)**** | −0.08/0.92 (0.89–0.95)**** | −0.08/0.92 (0.90–0.95)**** |
| −0.12/0.89 (0.84–0.94)**** | −0.12/0.89 (0.84–0.94)**** | −0.12/0.89 (0.84–0.94)**** | |
| −0.06/0.94 (0.90–0.98)*** | −0.07/0.94 (0.90–0.98)*** | −0.07/0.94 (0.90–0.98)*** | |
| Neighborhood income 4th quantile versus 1st quantile | −0.11/0.90 (0.87–0.93)**** | −0.11/0.90 (0.87–0.93)**** | −0.11/0.90 (0.87–0.93)**** |
| −0.19/0.83 (0.79–0.87)**** | −0.19/0.83 (0.76–0.87)**** | −0.19/0.83 (0.79–0.88)**** | |
| −0.05/0.95 (0.91–0.99)*** | −0.05/0.95 (0.91–0.99)*** | −0.05/0.95 (0.91–0.99)*** | |
| Neighborhood income 5th quantile versus 1st quantile | −0.15/0.86 (0.83–0.89)**** | −0.15/0.86 (0.83–0.89)**** | −0.15/0.86 (0.83–0.89)**** |
| −0.23/0.80(0.750–0.84)**** | −0.23/0.80 (0.76–0.84)**** | −0.23/0.80 (0.76–0.84)**** | |
| −0.10/0.90 (0.86–0.94)**** | −0.10/0.90 (0.86–0.94)**** | −0.10/0.90 (0.86–0.94)**** | |
| Cerebrovascular disease (yes vs. no) | 0.36/1.43 (1.37–1.48)**** | 0.36/1.43(1.38–1.48)**** | 0.36/1.43 (1.38–1.481)**** |
| 0.37/1.45 (1.37–1.53)**** | 0.37/1.45 (1.38–1.53)**** | 0.37/1.45 (1.37–1.528)**** | |
| 0.34/1.40 (1.33–1.48)**** | 0.34/1.40 (1.33–1.48)**** | 0.34/1.40 (1.33–1.478)**** | |
| Ischemic heart disease (yes vs. no) | −0.11/0.90 (0.87–0.93)**** | −0.11/0.90 (0.87–0.93)**** | −0.11/0.90 (0.87–0.93)**** |
| −0.16/0.85 (0.81–0.90)**** | −0.16/0.85 (0.81–0.90)**** | −0.16/0.85 (0.81–0.90)**** | |
| −0.06/0.94 (0.90–0.98)*** | −0.07/0.94 (0.90–0.98)*** | −0.06/0.94 (0.90–0.98)*** | |
| Diseases of arteries, arterioles and capillaries (yes vs. no) | 0.11/1.12 (1.05–1.19)*** | 0.11/1.12 (1.05–1.19)*** | 0.11/1.12 (1.05–1.19)*** |
| 0.16/1.18 (1.08–1.28)*** | 0.16/1.18 (1.08–1.28)*** | 0.16/1.18 (1.08–1.28)*** | |
| 0.03/1.03 (0.94–1.14) | 0.03/1.03 (0.94–1.14) | 0.03/1.03 (0.94–1.14) | |
| Atrial fibrillation (yes vs. no) | −0.06/0.94 (0.91–0.98)*** | −0.06/0.95 (0.91–0.98)*** | −0.06/0.95 (0.91–0.98)*** |
| −0.07/0.93 (0.88–0.99)*** | −0.07/0.94 (0.884–0.99)*** | −0.07/0.94 (0.88–0.99)*** | |
| −0.05/0.95 (0.91–1.00) | −0.05/0.95 (0.91–1.00) | −0.05/0.95 (0.91–1.00) | |
| Heart failure (yes vs. no) | 0.15/1.16 (1.110–1.21)**** | 0.15/1.16 (1.11–1.21)**** | 0.15/1.16 (1.11–1.21)**** |
| 0.18/1.20 (1.13–1.28)**** | 0.18/1.20 (1.13–1.28)**** | 0.18/1.20 (1.13–1.28)**** | |
| 0.121.13 (1.06–1.19)**** | 0.12/1.13 (1.06–1.19)**** | 0.12/1.13 (1.06–1.19)**** | |
| Obesity (yes vs. no) | −0.05/0.95 (0.84–1.08) | −0.05/0.95 (0.834–1.08) | −0.05/0.95 (0.83–1.08) |
| −0.12/0.89 (0.70–1.11) | −0.13/0.88 (0.70–1.11) | −0.13/0.88 (0.70–1.11) | |
| −0.01/0.99 (0.85–1.16) | −0.01/0.99 (0.85–1.16) | −0.01/0.99 (0.85–1.15) | |
| Tobacco smoking (yes vs. no) | 0.67/1.95 (1.45–2.56)**** | 0.66/1.94 (1.48–2.56)**** | 0.67/1.95 (1.48–2.56)**** |
| 0.42/1.52 (1.02–2.28)*** | 0.42/1.520 (1.02–2.27)*** | 0.42/1.53 (1.02–2.28)*** | |
| 0.91/2.49 (1.71–3.64)**** | 0.91/2.491 (1.71–3.64)**** | 0.91/2.49 (1.70–3.63)**** | |
| Hyperlipidemia (yes vs. no) | 0.04/1.04 (0.99–1.099) | 0.04/1.04 (0.99–1.09) | 0.04/1.04 (0.99–1.09) |
| 0.09/1.10 (1.02–1.18)*** | 0.09/1.09 (1.02–1.18)*** | 0.09/1.09 (1.02–1.18)*** | |
| −0.00/1.00 (0.93–1.07) | −0.01/0.99 (0.93–1.07) | −0.00/1.00 (0.93–1.07) | |
| Diabetes mellitus (yes vs. no) | 0.38/1.46 (1.42–1.50)**** | 0.38/1.457 (1.42–1.50)**** | 0.38/1.46 (1.42–1.50)**** |
| 0.40/1.49 (1.42–1.55)**** | 0.39/1.484 (1.42–1.55)**** | 0.40/1.49 (1.42–1.55)**** | |
| 0.36/1.44(1.38–1.49)**** | 0.36/1.435 (1.38–1.49)**** | 0.36/1.44 (1.38–1.49)**** | |
| Depression (yes vs. no) | 0.60/1.82(1.73–1.91)**** | 0.60/1.82 (1.73–1.91)**** | 0.59/1.811 (1.72–1.91)**** |
| 0.70/2.01 (1.85–2.18)**** | 0.69/2.00 (1.85–2.18)**** | 0.70/2.004 (1.85–2.18)**** | |
| 0.54/1.71 (1.61–1.83)**** | 0.54/1.71 (1.61–1.83)**** | 0.54/1.709 (1.60–1.82)**** | |
| Vision impairments (yes vs. no) | −0.06/0.95 (0.89–1.00) | −0.06/0.946 (0.89–1.01) | −0.06/0.95 (0.89–1.00) |
| −0.01/0.99 (0.91–1.09) | −0.01/0.994 (0.91–1.09) | −0.01/1.00 (0.91–1.09) | |
| −0.09/0.92 (0.85–0.99)*** | −0.09/0.918 (0.85–0.99)*** | −0.09/0.92 (0.85–0.99)*** | |
| Hearing loss (yes vs. no) | 0.16/1.18 (1.01–1.37)*** | 0.16/1.18 (1.01–1.37)*** | 0.16/1.18 (1.01–1.37)*** |
| 0.21/1.24 (0.99–1.55) | 0.21/1.24 (0.99–1.55) | 0.21/1.24 (0.99–1.55) | |
| 0.12/1.13 (0.91–1.38) | 0.12/1.13 (0.92–1.39) | 0.12/1.13 (0.92–1.39) | |
| Sleep disorder (yes vs. no) | 0.22/1.25 (1.15–1.36)**** | 0.22/1.25 (1.15–1.36)**** | 0.22/1.25 (1.14–1.36)**** |
| 0.23/1.26 (1.11–1.42)*** | 0.22/1.25 (1.11–1.41)*** | 0.23/1.25 (1.11–1.41)*** | |
| 0.21/1.23 (1.09–1.40)*** | 0.21/1.24 (1.09–1.40)*** | 0.21/1.23 (1.09–1.40)*** | |
| Model fitting | |||
| LRχ2 | 111134.13**** | 111172.20**** | 111172.94**** |
| 52,654.88**** | 52,692.07**** | 52,686.80**** | |
| 54,048.52**** | 54,059.47**** | 54,057.45**** | |
| AIC | 735762.68 | 735688.60 | 735687.87 |
| 277549.06 | 277517.88 | 277519.15 | |
| 413829.46 | 413824.51 | 413822.52 | |
| Degree of freedom | 18 | 21 | 19 |
| 17 | 20 | 18 | |
| 17 | 20 | 18 | |
| Corrected C-index | 0.93 | 0.93 | 0.93 |
| 0.95 | 0.95 | 0.95 | |
| 0.90 | 0.90 | 0.90 | |
NOTE. Corrected C-index for all models ranged from 0.90 to 0.95.
ρ = level of significance: ***P < .001; ****P < .0001.
Abbreviations: AIC, Akaike information criterion; CI, confidence interval; CNS, central nervous system; HR, hazard ratio; LR, likelihood ratio; TBI, traumatic brain injury; SCI, spinal cord injury; Suppl., Supplement.
Significant nonlinearity was observed: a restricted cubic spline transformation was used.
Fig. 2(A) Proportional hazard ratio plots of the estimated risk of dementia versus patient age at first TBI event, and by TBI severity, after adjustment for sex and known risk factors. Mild TBI severity was used as a reference. (B) Proportional hazard ratio plots of the estimated risk of dementia versus patient age at first TBI event, and by TBI severity and by sex, after adjustment for known risk factors. Mild TBI severity was used as a reference. Abbreviations: F, female; M, male; TBI, traumatic brain injury.
Fig. 3(A) Proportional hazard ratio plots of the estimated risk of dementia versus patient age at first TBI event in the presence of comorbid SCI, after adjustment for sex and known risk factors. No SCI comorbidity was used as a reference. (B) Proportional hazard ratio plots of the estimated risk of dementia versus patient age at first TBI event in the presence of comorbid SCI, by sex, after adjustment for known risk factors. No SCI comorbidity was used as a reference. Abbreviations: F, female; M, male; TBI, traumatic brain injury; SCI, spinal cord injury.